Daniela Gruber

Daniela Gruber is an experienced professional who has held various leadership positions in the pharmaceutical industry. Currently serving as the Director Portfolio Optimization at AOP Orphan Pharmaceuticals GmbH. Daniela has a strong background in business unit management, particularly in the areas of neurology, metabolic disorders, psychiatry, gastroenterology, gynaecology, and endocrinology. With a solid educational background from WU and the University of Graz, Daniela has also worked in marketing, product management, and consulting roles at reputable companies like ImClone Systems, sanofi-aventis, GlaxoSmithKline, and more.